PIP - PharmAthene, Inc

NYSE American - NYSE American Delayed Price. Currency in USD
-0.05 (0.00%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close0.70
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.63 - 0.73
52 Week Range0.63 - 0.73
Avg. VolumeN/A
Market CapN/A
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Accesswire10 months ago

    Today's Research Reports on Biotech Stocks to Watch: AVEO Pharmaceuticals and PharmAthene

    NEW YORK, NY / ACCESSWIRE / May 5, 2017 / AVEO Pharmaceuticals, Inc. and PharmaAthene both saw losses in Thursday trading after Wall Street didn't care much for the losses both companies had in the first ...

  • Associated Press10 months ago

    PharmAthene reports 1Q loss

    On a per-share basis, the Annapolis, Maryland-based company said it had a loss of 3 cents. The biodefense company that develops countermeasures against biological and chemical threats posted revenue of ...

  • PR Newswire10 months ago

    PharmAthene Reports First Quarter 2017 Financial and Operational Results

    ANNAPOLIS, Md., May 3, 2017 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today reported its financial and operational results ...

  • Capital Cube11 months ago

    ETFs with exposure to PharmAthene, Inc. : April 7, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to PharmAthene, Inc. Here are 5 ETFs with the largest exposure to PIP-US. Comparing the performance and risk of PharmAthene, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • PharmAthene, Inc. :PIP-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017
    Capital Cubelast year

    PharmAthene, Inc. :PIP-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017

    Categories: Yahoo Finance Get free summary analysis PharmAthene, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of PharmAthene, Inc. – Emergent BioSolutions Inc., Pfizer Inc., Dynavax Technologies Corporation, Baxter International Inc., Cempra, Inc., Johnson & Johnson, XOMA Corporation and SIGA Technologies Inc (EBS-US, PFE-US, DVAX-US, BAX-US, ... Read more (Read more...)